AMP-activated protein kinase positively regulates FGF-2-stimulated VEGF synthesis in osteoblasts

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 123-127

  Kato, Kenji ^a,b   Tokuda, Haruhiko ^b,c   Adachi, Seiji ^b   Matsushima Nishiwaki, Rie ^b   Natsume, Hideo ^a,b   Yamakawa, Kengo ^b   Gu, Yumi ^b   Otsuka, Takanobu ^a   Kozawa, Osamu ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

AMPK; FGF 2; Osteoblast; VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; STRESS ACTIVATED PROTEIN KINASE 1; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION;

3T3-L1 CELLS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; FIBROBLAST GROWTH FACTOR 2; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 8; OSTEOBLASTS; PHOSPHORYLATION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84655161207     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.024     Document Type: Article

References (31)

1. Beg Z.H., Allmann D.W., Gibson D.M. Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol. Biochem. Biophys. Res. Commun. 1973, 54:1362-1369.
2. Carlson C.A., Kim K.H. Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J. Biol. Chem. 1973, 248:378-380.
3. Rutter G.A., Leclerc I. The AMP-regulated kinase family: enigmatic targets for diabetes therapy. Mol. Cell Endocrinol. 2009, 297:41-49.
4. Stapleton D., Gao G., Michell B.J., Widmer J., Mitchelhill K., Teh T., House C.M., Witters L.A., Kemp B.E. Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J. Biol. Chem. 1994, 269:29343-29346.
5. Hawley S.A., Davison M., Woods A., Davies S.P., Beri R.K., Carling D., Hardie D.G. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271:27879-27887.
6. Fogarty S., Hardie D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 1996, 271:27879-27887.
7. Kurth-Kraczek E.J., Hirshman M.F., Goodyear L.J., Winder W.W. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48:1667-1671.
8. Zhou W., Han W.F., Landree L.E., Thupari J.N., Pinn M.L., Bililign T., Kim E.K., Vadlamudi A., Medghalchi S.M., El Meskini R., Ronnett G.V., Townsend C.A., Kuhajda F.P. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells. Cancer Res. 2007, 67:2964-2971.
9. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2002, 2:389-406.
10. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Sugimoto T. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMPK activation as well as eNOS and BMP-2 expression. Biochem. Biophys. Res. Commun. 2008, 375:414-419.
11. Shah M., Kola B., Bataveljic A., Arnett T.R., Viollet B., Saxon L., Korbonits M., Chenu C. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 2010, 47:309-319.
12. Baylink D.J., Finkelman R.D., Mohan S. Growth factors to stimulate bone formation. J. Bone Miner. Res. 1993, 8(Suppl. 2):S565-572.
13. Hurley M.M., Abreu C., Harrison J.R., Lichtler A.C., Raisz L.G., Kream B.E. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 1993, 268:5588-5593.
14. Bolander M.E. Regulation of fracture repair by growth factors. Proc. Soc. Exp. Biol. Med. 1992, 200:165-170.
15. Johnson D.E., Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 1993, 60:1-41.
16. Suzuki A., Shinoda J., Kanda S., Oiso Y., Kozawa O. Basic fibroblast growth factor stimulates phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells. J. Cell Biochem. 1996, 63:491-499.
17. Zelzer E., Olsen B.R. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development growth and repair. CurrTop. Dev. Biol. 2005, 65:169-187.
18. Erlebacher A., Filvaroff E.H., Gitelman S.E., Derynck R. Toward a molecular understanding of skeletal development. Cell 1995, 80:371-378.
19. Tokuda H., Kozawa O., Uematsu T. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J. Bone Miner. Res. 2000, 15:2371-2379.
20. Tokuda H., Hirade K., Wang X., Oiso Y., Kozawa O. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J. Endocrinol. 2003, 177:101-107.
21. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81:807-869.
22. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 1983, 96:191-198.
23. Kozawa O., Tokuda H., Miwa M., Kotoyori J., Oiso Y. Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cells. Exp. Cell Res. 1992, 198:130-134.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Kato K., Ito H., Hasegawa K., Inaguma Y., Kozawa O., Asano T. Modulation of the stress-induced synthesis of hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells. J. Neurochem. 1996, 66:946-950.
26. Simpson D.A., Feeney S., Boyle C., Stitt A.W. Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol. Vis. 2000, 6:178-183.
27. Saadeh P.B., Mehrara B.J., Steinbrech D.S., Spector J.A., Greenwald J.A., Chin G.S., Ueno H., Gittes G.K., Longaker M.T. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 2000, 141:2075-2083.
28. Warden S.M., Richardson C., O'Donnell J., Stapleton D., Kemp B.E., Witters L.A. Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 2001, 354:275-283.
29. Kim J.E., Ahn M.W., Baek S.H., Lee I.K., Kim Y.W., Kim J.Y., Dan J.M., Park S.Y. AMPK activator AICAR inhibits palmitate-induced apoptosis in osteoblast. Bone 2008, 43:394-404.
30. Srinivas V., Bohensky J., Zahm A.M., Shapiro I.M. Autophagy in mineralizing tissues: microenvironmental perspectives. Cell Cycle 2009, 8:391-393.
31. Unnanuntana A., Gladnick B.P., Donnelly E., Lane J.M. The assessment of fracture risk. J. Bone Joint Surg. Am. 2010, 92:43-753.